Joanne M. Foody is Chief Medical Officer at Esperion Therapeutics, Inc. (ESPR). They have made 8 open-market trades across 1 company since 2022, most recently 2024-07-17.
CIK 0001871467
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ESPR | 272,862 | $870K |
Shares reported on the most recent Form 4, priced at the 2024-07-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ESPR | SELL | 2024-07-17 | 2024-07-19 | $2.60 | $2K | -4.5% | -21.5% | -12.8% |
| ESPR | SELL | 2024-06-18 | 2024-06-20 | $2.87 | $9K | +0.9% | +3.9% | -25.0% |
| ESPR | SELL | 2023-04-19 | 2023-04-20 | $1.27 | $1K | +3.9% | +30.7% | +21.3% |
| ESPR | SELL | 2023-03-17 | 2023-03-20 | $1.78 | $7K | +8.4% | -14.9% | -0.6% |
| ESPR | SELL | 2023-03-07 | 2023-03-08 | $5.07 | $20K | -69.3% | -72.7% | -72.7% |
| ESPR | SELL | 2023-01-18 | 2023-01-19 | $6.99 | $8K | -7.2% | -18.4% | -80.9% |
| ESPR | SELL | 2022-10-18 | 2022-10-19 | $7.69 | $7K | +3.0% | -8.6% | -11.3% |
| ESPR | SELL | 2022-07-19 | 2022-07-20 | $6.55 | $26K | -16.3% | +13.5% | +22.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.